C. Bolliger (Cape Town, South Africa), S. Gasparini (Ancona, Italy)
The role of PET-CT in patients undergoing trans bronchial needle aspiration (TBNA) with rapid on-site evaluation (rROSE). Establishing an FDG uptake cutoff
L. Seijo, J. P. De Torres, M. D. Lozano, A. Campo, A. B. Alcaide, E. Martino, M. J. Garcia, J. Zulueta (Pamplona, Spain)
|   |
Additional value of histological specimens obtained by 19G TBNA needle in diagnosing malignant mediastinal lesions
G. Stratakos, C. Kandaraki, E. Porfyridis, V. Pappas, C. Zisis, A. Liapikou, C. Roussos, S. Zakynthinos (Athens, Greece)
|  |
Value of histology over cytology in TBNA: cytology alone not always reliable
F. Hermens, B. Hoevenaars, F. Thunnissen, J. Janssen (Nijmegen, Netherlands)
| |
Real time EBUS TBNA in hilar and conventional TBNA negative mediastinal lymphadenopathy
P. Chhajed, R. Odermatt, C. von Garnier, M. Brutsche, M. Tamm (Basel, Switzerland)
| |
Multimodality bronchoscopic diagnosis of peripheral lung lesions: a randomized controlled trial
R. Eberhardt, A. Ernst, D. Anantham, F. J. F. Herth (Heidelberg, Germany; Boston, MA, United States Of America)
| |
Feasibility, yield and impact of ambulatory EBUS-TBNA for the diagnosis and staging of lung cancer
J. Annema, M. Veselic, K. Rabe (Leiden, Netherlands)
| |
Impact of endoscopic ultrasound in the staging of lung cancer patients: does lymph node size matter?
K. G. Tournoy, L. Vanwalleghem, F. De Rijck, M. Praet, F. Vermassen, G. Van Maele, J. van Meerbeeck (Ghent, Belgium)
| |
Electromagnetically navigated bronchoscopy and endobronchial ultrasound for brachytherapy of inoperable peripheral lung cancer – a prospective feasibility and safety study
H. D. Becker, W. Harms (Heidelberg, Germany)
| |